Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death

Diabetes

Volumn 51, Issue 4, 2002, Pages 1157-1165

  Stehouwer, Coen D A ^a   Gall, Mari Anne ^b   Twisk, Jos W R ^c   Knudsen, Elisabeth ^b   Emeis, Jef J ^d   Parving, Hans Henrik ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b STENO DIABETES CENTER   (Denmark)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN; GLYCOSYLATED HEMOGLOBIN; SELECTIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

EID: 0036224765     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1157     Document Type: Article

References (27)

1. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature
2. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: The Insulin Resistance Atherosclerosis Study (IRAS)
3. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study
4. Coronary atherosclerosis in type II diabetes: Angiographic findings and clinical outcome
5. Atherosclerosis: An inflammatory disease
6. Endothelial dysfunction and the pathogenesis of diabetic angiopathy
7. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
8. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation
9. Albuminuria, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus
10. Endothelial dysfunction precedes development of microalbuminuria in insulin-dependent diabetes mellitus
11. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: A 4-year prospective study
12. Von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects: The Hoorn Study
13. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes
14. Albuminuria and poor glycemic control predict mortality in NIDDM
15. 1c by thinlayer isoelectric focusing
16. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria
17. Enzyme immunoassay: An improved determination of urinary albumin in diabetics with incipient nephropathy
18. A sensitive ELISA for von Willebrand factor (vWF:Ag)
19. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
20. Light-scattering immunoassay of specific proteins
21. Longitudinal data analysis for discrete and continuous outcomes
22. Different statistical models to analyse epidemiological observational longitudinal data
23. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
24. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
25. Leptin induces direct vasodilation through distinct endothelial mechanisms
26. Amadori-albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy and localization in retinal capillaries
27. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept